Metrocare tablets 250 mg
Metrocare tablets 250 mg
Authorised
- Metronidazole
Product identification
Medicine name:
Metrocare tablets 250 mg
Metrocare Vet 250 mg Tablett
Active substance:
- Metronidazole
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Metronidazole250.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XD01
- QP51AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Available in:
-
Sweden
Package description:
- PVC Aluminium Oriented polyamide Aluminium blister packs.Cardboard box of 7 blisters. Pack size 70 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 9 blisters. Pack size 90 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 8 blisters. Pack size 80 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 6 blisters. Pack size 60 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 50 blisters. Pack size 500 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 5 blisters. Pack size 50 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 4 blisters. Pack size 40 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 3 blisters. Pack size 30 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 25 blisters. Pack size 250 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 2 blisters. Pack size 20 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 10 blisters. Packsize 100 tablets.
- PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 1 blister. Pack size 10 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 57536
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0239/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Hungary
-
Ireland
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 2/05/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 2/05/2022
How useful was this page?: